Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

First Korean/U.S. workshop on drug regulation and marketing

Getting more and better drugs to market for patients was the ultimate goal of the University of Maryland School of Pharmacy's first Korean/U.S. workshop on drug regulation and marketing from March 18 to 22.

6 Apr 2013

Arena Pharmaceuticals kicks off APD334 Phase 1 clinical trial for treatment of autoimmune diseases

Arena Pharmaceuticals, Inc. announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of autoimmune diseases.

6 Apr 2013

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Vertex Pharmaceuticals Incorporated today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex's nucleotide analogue hepatitis C virus polymerase inhibitor VX-135 and Bristol-Myers Squibb's NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.

6 Apr 2013

Only 50% people with arthritis report significant improvement after hip or knee replacement

Only half of people with arthritis who had a hip or knee replacement reported a significant improvement in pain and mobility after surgery, according to a new study led by Women's College Hospital and the Institute for Clinical and Evaluative Sciences (ICES).

5 Apr 2013

USPTO issues Notice of Allowance on Antares Pharma's patent application for VIBEX QS device

Antares Pharma, Inc. announced that it has received a Notice of Allowance from the U.S. Patent Trade Office on a patent application for the VIBEX QuickShot device, the latest advancement in its proprietary line of VIBEX auto-injector systems.

5 Apr 2013

UEA research could offer long-lasting solution to eating disorders

Researchers at the University of East Anglia have made a discovery in neuroscience that could offer a long-lasting solution to eating disorders such as obesity.

5 Apr 2013

Dermatology researcher secures federal grant to explore psoriasis

A dermatology researcher at Case Western Reserve University School of Medicine has secured a five-year, $1.9 million federal grant to explore whether a specific molecule may play a pivotal role in the development and progression of psoriasis.

5 Apr 2013

TSRI scientists identify new drugs for human prion disease

Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.

4 Apr 2013

Same factor that helps fight off severe inflammatory ailments also functions as enemy

The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.

4 Apr 2013

Ulcerative colitis and Crohn’s disease treatments: an interview with Dr Parikh, vice president, general medicine, Takeda

Ulcerative colitis (UC) and Crohn’s disease (CD) are both relapsing and remitting chronic diseases of bowel inflammation. By that I mean they flare and physicians try to get the flare under control and try to induce remission. However, despite a number of treatments available, they tend to relapse.

From Takeda 3 Apr 2013

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.

3 Apr 2013

Researchers identify link between immune response and blood clotting

Rice University researchers have found an unexpected link between a protein that triggers the formation of blood clots and other proteins that are essential for the body's immune system.

2 Apr 2013

Ampio Pharmaceuticals receives FDA IND approval to start clinical trial of Ampion

Ampio Pharmaceuticals, Inc. today announced FDA acceptance of its IND and the treatment of the first fifteen (15) patients in its clinical trial using Ampion™ to treat osteoarthritis of the knee.

2 Apr 2013

Lifestyle choices we make in adulthood influence how tall we stand as we age

Even if you didn't eat your veggies or drink your milk as a child, your height is still in your hands, reveal new findings by economists from the University of Southern California, Harvard University and Peking University.

2 Apr 2013

Ensemble Therapeutics to highlight IL-17A inhibitor Ensemblin at 245th ACS National Meeting

Ensemble Therapeutics today announced that preclinical data showing the advantages of its Ensemblins, novel macrocyclic compounds against challenging drug targets, will be presented at the 245th American Chemical Society National Meeting being held April 7-11, 2013 in New Orleans, LA.

2 Apr 2013

Research findings could lead to new targets for treating inflammatory disorders

Researchers at UC Davis have shown how the innate immune system distinguishes between dangerous pathogens and friendly microbes. Like burglars entering a house, hostile bacteria give themselves away by breaking into cells. However, sensing proteins instantly detect the invasion, triggering an alarm that mobilizes the innate immune response.

2 Apr 2013

Two nationally renowned specialists to research on Lupus, auto-immune disorders

In a new association of nationally renowned specialists on Lupus and auto-immune disorders, Dr. Swamy Venuturupalli , is joining with Dr. Daniel Wallace to accelerate research into those diseases along with their expanded clinical practice.

1 Apr 2013

Research findings could improve treatments for pneumonia, other inflammatory conditions

Scientists at the University of Pittsburgh School of Medicine have discovered a new biological pathway of innate immunity that ramps up inflammation and then identified agents that can block it, leading to increased survival and improved lung function in animal models of pneumonia.

1 Apr 2013

New technique for vaccine design could prove useful against HIV, other viral strains

A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.

30 Mar 2013

Shriners Hospitals for Children -- Twin Cities become the newest member of the Mayo Clinic Care Network

Mayo Clinic today announced that Shriners Hospitals for Children -- Twin Cities (Shriners) will build on the decades-long collaboration between physicians in both organizations and become part of the Mayo Clinic Care Network.

29 Mar 2013

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

First Korean/U.S. workshop on drug regulation and marketing

Arena Pharmaceuticals kicks off APD334 Phase 1 clinical trial for treatment of autoimmune diseases

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Only 50% people with arthritis report significant improvement after hip or knee replacement

USPTO issues Notice of Allowance on Antares Pharma's patent application for VIBEX QS device

UEA research could offer long-lasting solution to eating disorders

Dermatology researcher secures federal grant to explore psoriasis

TSRI scientists identify new drugs for human prion disease

Same factor that helps fight off severe inflammatory ailments also functions as enemy

Ulcerative colitis and Crohn’s disease treatments: an interview with Dr Parikh, vice president, general medicine, Takeda

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Researchers identify link between immune response and blood clotting

Ampio Pharmaceuticals receives FDA IND approval to start clinical trial of Ampion

Lifestyle choices we make in adulthood influence how tall we stand as we age

Ensemble Therapeutics to highlight IL-17A inhibitor Ensemblin at 245th ACS National Meeting

Research findings could lead to new targets for treating inflammatory disorders

Two nationally renowned specialists to research on Lupus, auto-immune disorders

Research findings could improve treatments for pneumonia, other inflammatory conditions

New technique for vaccine design could prove useful against HIV, other viral strains

Shriners Hospitals for Children -- Twin Cities become the newest member of the Mayo Clinic Care Network

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in